Feed Preview

Fast Growing

Cancer Disparities

Cancer Disparities diagram by Yoo et al, PLOS One
Yoo et al, PLOS One

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Top 20 most recent papers
Advances in Cancer Research

Race differences in mobility status among prostate cancer survivors: The role of socioeconomic status

Advances in Cancer ResearchApril 4, 2020
Roland J ThorpeThomas A LaVeist
Journal of Genetic Counseling

Ethnic disparities in the frequency of cancer reported in family histories

Journal of Genetic CounselingMarch 30, 2020
Heather MavesMoyra Smith
Advances in Cancer Research

Racial/ethnic disparities in ovarian cancer research

Advances in Cancer ResearchApril 4, 2020
Lauren C Peres, Joellen M Schildkraut
Advances in Cancer Research

Pubertal mammary development as a "susceptibility window" for breast cancer disparity

Advances in Cancer ResearchApril 4, 2020
Bradley KrisanitsDavid P Turner
Journal of Translational Medicine

Ethnicity and survival in bladder cancer: a population-based study based on the SEER database

Journal of Translational MedicineApril 2, 2020
Wei FangChao Zhang
Advances in Cancer Research

Project PLACE: Enhancing community and academic partnerships to describe and address health disparities

Advances in Cancer ResearchApril 4, 2020
Nadine J BarrettSteven R Patierno
Iranian Journal of Allergy, Asthma, and Immunology

Association of rs1946518 C/A Polymorphism in Promoter Region of Interleukin 18 Gene and Breast Cancer Risk in Iranian Women: A Case-control Study

Iranian Journal of Allergy, Asthma, and ImmunologyApril 5, 2020
Nazila Fathi MaroufiBehzad Baradaran

See more papers from this feed

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2020 Meta ULC. All rights reserved